Psychedelic Medicine


Psychedelic Medicine


Stay informed


welcome to the PMA resource library

Iboga, full name Tabernanthe iboga, is the main plant from which ibogaine is extracted. Ibogaine can also be synthesized in a lab. Treatments can be with either iboga, the full plant, or ibogaine alone. 

It has been known to relieve people of their addictions in as little as one treatment, having helped those with addictions from opiates to alcohol to amphetamines and beyond. Reports say that it helps both alleviate withdrawal symptoms and also to keep cravings at bay. It has been associated with a small number of deaths, most of which are thought to be due to pre-existing heart conditions or medication interactions and not due solely to the ibogaine itself. 

Ibogaine is illegal in the US and much of Europe, but is legal in Mexico, Brazil, Costa Rica, South Africa, Gabon, New Zealand, and the Netherlands.


Psychedelic treatment for co-occurring alcohol misuse and post-traumatic stress symptoms among United States Special Operations Forces Veterans

Pratheek Mangini, Lynnette A. Averill
November 2021

A new approach methodology (NAM) for the prediction of (nor)ibogaine-induced cardiotoxicity in humans

Miaoying Shi, Sebastiaan Wesseling, Hans Bouwmeester and Ivonne M. C. M. Rietjens
July 2021

Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans

Alan K. Davis, Lynnette A. Averill, Nathan D. Sepeda, Joseph P. Barsuglia, Timothy Amoroso
July 2020

Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes

Deborah C. Mash, Linda Duque, Bryan Page, and Kathleen Allen-Ferdinand
June 2018
Other Links


Join the discussion. Have your say and share your thoughts with like-minded medical professionals.

Learn More